Vimarsana
Biggest News Aggregation in the World

Page 2 - Associate Commissioner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Associate Commissioner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Associate Commissioner Today - Breaking & Trending Today

Six-year Housing Affordability Strategy unanimously backed by council - Vimarsana News

Six-year Housing Affordability Strategy unanimously backed by council

After years of discussions, task forces, studies, and reports, the rubber might finally meet the road for creating more local affordable housing.

Six-year Housing Affordability Strategy unanimously backed by council | Drayton Valley Western Review - Vimarsana News

Six-year Housing Affordability Strategy unanimously backed by council | Drayton Valley Western Review

After years of discussions, task forces, studies, and reports, the rubber might finally meet the road for creating more local affordable housing.

Patients' Voices Largely Absent From FDA Reviews of New Cancer Drugs - Vimarsana News

Patients' Voices Largely Absent From FDA Reviews of New Cancer Drugs

The FDA encourages collection and reporting of patient-reported outcomes (PROs) in clinical trials, but a substantial proportion of applications seeking product approval lack these data. Assessment of patient-reported outcomes in clinical trials is on the rise, but they frequently are absent from requests for FDA drug approvals.

Source: empr.com
Coastal Resiliency Project designed to protect Manhattan from flooding - Vimarsana News

Coastal Resiliency Project designed to protect Manhattan from flooding

MANHATTAN, N.Y. (PIX11) — The East Side Coastal Resiliency Project is now about 40% complete, according to New York City officials. It’s a $1.4 billion investment to prevent devastating flooding like what New York City experienced during Superstorm Sandy. PIX11 News was granted access to tour the construction site on the Lower East Side on […]

Source: yahoo.com
Patients' Voices Largely Absent From FDA Reviews of New Cancer Drugs Patient Reported Outcomes Largely Absent From FDA Reviews of New Cancer Drugs- Renal and Urology News - Vimarsana News

Patients' Voices Largely Absent From FDA Reviews of New Cancer Drugs Patient Reported Outcomes Largely Absent From FDA Reviews of New Cancer Drugs- Renal and Urology News

The FDA encourages collection and reporting of patient-reported outcomes (PROs) in clinical trials, but a substantial proportion of applications seeking product approval lack these data. Assessment of patient-reported outcomes in clinical trials is on the rise, but they frequently are absent from requests for FDA drug approvals.